Brief: BioArctic's Leqembi Approved For Treatment Of Alzheimer's Disease In China

BioArctic AB (publ)

09/01/2024 08:33

Jan 9 (Reuters) - BioArctic AB  BIOAb.ST :
    * LEQEMBI® APPROVED FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN
CHINA
    * EISAI ANNOUNCED THAT LEQEMBI HAS BEEN APPROVED IN CHINA AS
REATMENT FOR MILD COGNITIVE IMPAIRMENT AND MILD AD DEMENTIA
    * EISAI'S PREPARATIONS FOR CHINESE LAUNCH IN OF Q3 2024 ARE
UNDERWAY

Source text for Eikon:  ID:nWkr1MfjQS 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))